Kidswell Bio Corporation

4584

TSE PrimePharmaceuticals

¥ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement (PL) Summary

Updated: 2026-08-13FY2027 Q1

Revenue

61.4100M JPY

YoY -2.9%

Operating Income

2.2100M JPY

YoY +17.3%

Net Income

-3.7100M JPY

YoY -219.4%

EPS

4.0JPY

YoY +20.5%

Performance Trend

Revenue, operating income and net income trend (last 5 periods)

RevenueOperatingNet Income

65.9億円

45.9億円

25.8億円

5.8億円

-14.2億円

Rev: 15.7億円Op: -9.2億円NI: -5.4億円

Rev: 27.8億円Op: -5.5億円NI: -6.6億円

Rev: 24.3億円Op: -13.4億円NI: -14.2億円

Rev: 50.8億円Op: 27.9百万円NI: -21.1百万円

Rev: 65.9億円Op: -1.4億円NI: -4.1億円

2022/FY2023/FY2024/FY2025/FY2026/FY

Full-Year Progress

FY2027 Q1

Net Income-

Revenue Progress12.700M

Revenue Forecast-

Net Income Progress200M

Net Income Forecast-

Income Statement Details

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan